Brought to you by:
Bioprosthetic venous valve imparts sustained clinical improvement at one year regardless of CEAP category
A new paper that drills into the impact of a novel bioprosthetic venous valve replacement by CEAP (Clinical, Etiological, Anatomical and Pathophysiological) classification shows sustained clinical improvement regardless of grading, with patients classed as C4b exhibiting greater resolution of symptoms…
Muck takes over Midwestern Vascular Surgical Society presidency
Patrick Muck, MD, assumed the reins of the Midwestern Vascular Surgical Society (MVSS) at the conclusion of the 2024 MVSS annual meeting in Chicago (Sept. 12–14). The chief of vascular surgery at Good Samaritan Hospital in Cincinnati, Ohio, took over…
MVSS 2023: Human Acellular Vessel proves ‘safe, effective bypass conduit’ in complex CLTI cohort
An investigator-sponsored clinical study conducted at the Mayo Clinic in Rochester, Minnesota, of the investigational Human Acellular Vessel (HAV) in patients with chronic limb-threatening ischemia (CLTI) was presented at the Midwestern Vascular Surgical Society (MVSS) annual meeting in Minneapolis, Minnesota…
MVSS president outlines why vascular surgery is special and how ‘people need to know what we do’
Outgoing Midwestern Vascular Surgical Society (MVSS) President Jeffrey Jim, MD, used his recent presidential address to call upon vascular surgeons to spread the word far and wide—from Main Street to hospital C-suites—of what marks out vascular surgery as the truly…
MVSS 2023: Aulivola takes over Midwestern Vascular reins
Bernadette Aulivola, MD, the division director of vascular surgery and endovascular therapy at Loyola University in Maywood, Illinois, took over as president of the Midwestern Vascular Surgical Society (MVSS) at the conclusion of the MVSS annual business meeting held in…
The top 10 most popular Vascular Specialist stories of December 2022
Among the most-read Vascular Specialist stories in December 2022 were the promising results from a postmarket surveillance study of a paclitaxel DCB; the Society for Vascular Surgery (SVS) paid tribute to the passing of former president James (Jimmy) S.T. Yao,…
MVSS 2022: Study finds no link between frailty score and surgical site infection
A vascular surgery-specific composite frailty score was not associated with with risk of surgical site infection in patients undergoing lower-extremity revascularization in a review carried out by Andrew Edsall, MD, a general surgery resident in the Gundersen Health System in…
CEA, TCAR ‘continue to show superior outcomes’ to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularization, with CEA and transcarotid artery revascularization (TCAR) showing decreased odds of stroke or death compared to transfemoral carotid artery stenting…
Study: Combined antiplatelet, NOAC use linked to worse limb outcomes after suprainguinal bypass
A new analysis that found combined antiplatelet and novel oral anticoagulant (NOAC) therapy after suprainguinal bypass was associated with worse limb outcomes and equivalent survival compared to antiplatelet use alone has “weaknesses” but is “hypothesis-generating,” the senior author insisted during…
MVSS 2022: Research on hemodialysis access surgery attracts inaugural Midwestern Vascular disparities award
The authors behind a new study that found “significant differences” in hemodialysis vascular access outcomes after first-time arteriovenous (AV) fistula or graft creation “directly related” to a patient’s race said the findings speak “to an injustice within the field of vascular surgery.” The research…